CAR-T cell therapy for multiple myeloma: a practical toolkit for treatment in Brazil.

ABSTRACT:

Introduction

Chimeric antigen receptor T (CAR-T) cell therapy is an emerging treatment option for relapsed/refractory multiple myeloma (RRMM) that is a multi-step process involving various stakeholders. Appropriate education on the practical logistics is therefore paramount to ensure treatment success.

Methods

A group of key opinion leaders met to explore the key elements of setting up and running a CAR-T center in Brazil. For each step in the CAR-T cell therapy process, the experts agreed on basic requirements, gave their key recommendations from practical experience, and considered any remaining unanswered questions.

Results

This paper presents best-practice recommendations and advice on how to overcome common challenges for each step in the CAR-T cell therapy proce

SUBMITTER: Hungria V 

PROVIDER: S-EPMC10244253 | biostudies-literature | 2023 Apr-Jun

REPOSITORIES: biostudies-literature